BHARAT IMMUNOLOGICALS (India) Price Prediction and Hype Density Breakdown

BIBCL -- India Stock  

INR 6.50  0.80  10.96%

We analyze noise-free headlines and recent hype associated with BHARAT IMMUNOLOGICALS BIOLOG which may create opportunities for some arbitrage if properly timed. With BHARAT IMMUNOLOGICALS hype-based prediction module you can estimate the value of BHARAT IMMUNOLOGICALS BIOLOG from the prospective of BHARAT IMMUNOLOGICALS response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on BHARAT IMMUNOLOGICALS over a specific investment horizon. Check also Trending Equities.
Horizon     30 Days    Login   to change

BHARAT IMMUNOLOGICALS After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

BHARAT IMMUNOLOGICALS Estimiated After-Hype Price Volatility

August 21, 2019
6.50
Current Value
6.51
After-hype Price
19.53
Upside
BHARAT IMMUNOLOGICALS is very risky asset. Analysis and calculation of next after-hype price of BHARAT IMMUNOLOGICALS is based on 2 months time horizon.

BHARAT IMMUNOLOGICALS Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.13% 4.34% 0.01%  0.25% 1 Events / Month3 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
6.506.510.15%
10,850% 

BHARAT IMMUNOLOGICALS Hype Timeline

BHARAT IMMUNOLOGICALS is currently traded for 6.50on Bombay Stock Exchange of India. The entity has historical hype elasticity of 0.01 and average elasticity to hype of competition of 0.25. BHARAT IMMUNOLOGICALS BIOLOG is anticipated to increase in value after the next headline with price going to jump to 6.51. The average volatility of media hype impact on the company stock price is about 10850.0%. The price increase on the next news is estimated to be 0.15% where as daily expected return is currently at -0.13%. The volatility of related hype on BHARAT IMMUNOLOGICALS is about 227.36% with expected price after next announcement by competition of 6.75. The company reported revenue of 836.45M. Net Loss for the year was (55.57M) with profit before overhead, payroll, taxes, and interest of 103.65M. Assuming 30 trading days horizon, the next anticipated press release will be very soon.
Check also Trending Equities.

BHARAT IMMUNOLOGICALS Related Hype Analysis

Check also Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.
Search macroaxis.com